The US Food and Drug Administration (FDA) has announced new action to encourage companies to develop naloxone products for over-the-counter (OTC) use — or apply to switch certain products from prescription to nonprescription status. Naloxone is an opioid overdose reversal agent that can save lives when administered within minutes…